These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27311476)

  • 21. Quantitative structure-activity relationship methods: perspectives on drug discovery and toxicology.
    Perkins R; Fang H; Tong W; Welsh WJ
    Environ Toxicol Chem; 2003 Aug; 22(8):1666-79. PubMed ID: 12924569
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Use of toxicological information in drug design.
    Matthews EJ; Benz RD; Contrera JF
    J Mol Graph Model; 2000 Dec; 18(6):605-15. PubMed ID: 11155316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDA toxicity databases and real-time data entry.
    Arvidson KB
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):17-9. PubMed ID: 18656494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatotoxicity evaluation of traditional Chinese medicines using a computational molecular model.
    Zhao P; Liu B; Wang C;
    Clin Toxicol (Phila); 2017 Nov; 55(9):996-1000. PubMed ID: 28594241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A Toxicity Prediction Tool for Potential Agonist/Antagonist Activities in Molecular Initiating Events Based on Chemical Structures.
    Kurosaki K; Wu R; Uesawa Y
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33113912
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The EDKB: an established knowledge base for endocrine disrupting chemicals.
    Ding D; Xu L; Fang H; Hong H; Perkins R; Harris S; Bearden ED; Shi L; Tong W
    BMC Bioinformatics; 2010 Oct; 11 Suppl 6(Suppl 6):S5. PubMed ID: 20946616
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Critically Assessing the Predictive Power of QSAR Models for Human Liver Microsomal Stability.
    Liu R; Schyman P; Wallqvist A
    J Chem Inf Model; 2015 Aug; 55(8):1566-75. PubMed ID: 26170251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Kruhlak NL; Choi SS; Contrera JF; Weaver JL; Willard JM; Hastings KL; Sancilio LF
    Toxicol Mech Methods; 2008; 18(2-3):217-27. PubMed ID: 20020916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel automated lazy learning QSAR (ALL-QSAR) approach: method development, applications, and virtual screening of chemical databases using validated ALL-QSAR models.
    Zhang S; Golbraikh A; Oloff S; Kohn H; Tropsha A
    J Chem Inf Model; 2006; 46(5):1984-95. PubMed ID: 16995729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparing the performance of FLUFF-BALL to SEAL-CoMFA with a large diverse estrogen data set: from relevant superpositions to solid predictions.
    Korhonen SP; Tuppurainen K; Laatikainen R; Peräkylä M
    J Chem Inf Model; 2005; 45(6):1874-83. PubMed ID: 16309295
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Construction and analysis of a human hepatotoxicity database suitable for QSAR modeling using post-market safety data.
    Zhu X; Kruhlak NL
    Toxicology; 2014 Jul; 321():62-72. PubMed ID: 24721472
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Chemoinformatics-applications in food chemistry.
    Martinez-Mayorga K; Medina-Franco JL
    Adv Food Nutr Res; 2009; 58():33-56. PubMed ID: 19878857
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combinatorial QSAR of ambergris fragrance compounds.
    Kovatcheva A; Golbraikh A; Oloff S; Xiao YD; Zheng W; Wolschann P; Buchbauer G; Tropsha A
    J Chem Inf Comput Sci; 2004; 44(2):582-95. PubMed ID: 15032539
    [TBL] [Abstract][Full Text] [Related]  

  • 34. QSAR prediction of estrogen activity for a large set of diverse chemicals under the guidance of OECD principles.
    Liu H; Papa E; Gramatica P
    Chem Res Toxicol; 2006 Nov; 19(11):1540-8. PubMed ID: 17112243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enalos Suite: New Cheminformatics Platform for Drug Discovery and Computational Toxicology.
    Varsou DD; Nikolakopoulos S; Tsoumanis A; Melagraki G; Afantitis A
    Methods Mol Biol; 2018; 1800():287-311. PubMed ID: 29934899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of protein-protein interaction inhibitors by chemoinformatics and machine learning methods.
    Neugebauer A; Hartmann RW; Klein CD
    J Med Chem; 2007 Sep; 50(19):4665-8. PubMed ID: 17705363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prediction of Estrogenic Bioactivity of Environmental Chemical Metabolites.
    Pinto CL; Mansouri K; Judson R; Browne P
    Chem Res Toxicol; 2016 Sep; 29(9):1410-27. PubMed ID: 27509301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. QSAR-based permeability model for drug-like compounds.
    Gozalbes R; Jacewicz M; Annand R; Tsaioun K; Pineda-Lucena A
    Bioorg Med Chem; 2011 Apr; 19(8):2615-24. PubMed ID: 21458999
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is QSAR relevant to drug discovery?
    Doweyko AM
    IDrugs; 2008 Dec; 11(12):894-9. PubMed ID: 19051151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Why QSAR fails: an empirical evaluation using conventional computational approach.
    Huang J; Fan X
    Mol Pharm; 2011 Apr; 8(2):600-8. PubMed ID: 21370915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.